Blood Screening Market Size, Share, Growth, and Industry Analysis, By Type (First Generation, Second Generation, Third Generation, Fourth Generation & Above, Rapid Tests, Western Blot Assay, Next-generation Sequencing (NGS)), By Application (Blood Banks, Hospitals), Regional Insights and Forecast to 2035

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Blood Screening Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Blood Screening Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Blood Screening Business Mode and Production Process
2.3.1 Blood Screening Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Blood Screening Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Blood Screening
2.4.2 Raw Material Cost of Blood Screening
2.4.3 Labor Cost of Blood Screening
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Blood Screening Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Blood Screening Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Blood Screening Price by Manufacturer (2021-2026)
4.4 Blood Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Blood Screening, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Blood Screening, Product Offered and Application
4.7 Blood Screening Market Competitive Situation and Trends
4.7.1 Blood Screening Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Blood Screening Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Blood Screening Market Historical Development by Geographic Region (2021-2026)
5.1 Global Blood Screening Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Blood Screening Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Blood Screening Market Status by Country (2021-2026)
5.3.1 North America Blood Screening Sales Volume by Country (2021-2026)
5.3.2 North America Blood Screening Revenue by Country (2021-2026)
5.3.3 United States Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Blood Screening Market Status by Country (2021-2026)
5.4.1 Europe Blood Screening Sales Volume by Country (2021-2026)
5.4.2 Europe Blood Screening Revenue by Country (2021-2026)
5.4.3 Germany Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Blood Screening Market Status by Country (2021-2026)
5.5.1 Asia Pacific Blood Screening Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Blood Screening Revenue by Country (2021-2026)
5.5.3 China Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Blood Screening Market Status by Country (2021-2026)
5.6.1 Latin America Blood Screening Sales Volume by Country (2021-2026)
5.6.2 Latin America Blood Screening Revenue by Country (2021-2026)
5.6.3 Mexico Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Blood Screening Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Blood Screening Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Blood Screening Revenue by Country (2021-2026)
5.7.3 GCC Blood Screening Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Blood Screening Sales Volume, Revenue and Growth (2021-2026)

6 Global Blood Screening Market Historical Development by Product Type (2021-2026)
6.1 Blood Screening Definition by Type
6.2 Global Blood Screening Historical Sales Volume by Product Type (2021-2026)
6.3 Global Blood Screening Historical Revenue by Product Type (2021-2026)
6.4 Global Blood Screening Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Blood Screening Historical Sales Volume, Revenue and Growth Rate of First Generation (2021-2026)
6.5.2 Global Blood Screening Historical Sales Volume, Revenue and Growth Rate of Second Generation (2021-2026)
6.5.3 Global Blood Screening Historical Sales Volume, Revenue and Growth Rate of Third Generation (2021-2026)
6.5.4 Global Blood Screening Historical Sales Volume, Revenue and Growth Rate of Fourth Generation & Above (2021-2026)
6.5.5 Global Blood Screening Historical Sales Volume, Revenue and Growth Rate of Rapid Tests (2021-2026)
6.5.6 Global Blood Screening Historical Sales Volume, Revenue and Growth Rate of Western Blot Assay (2021-2026)
6.5.7 Global Blood Screening Historical Sales Volume, Revenue and Growth Rate of Next-generation Sequencing (NGS) (2021-2026)

7 Global Blood Screening Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Blood Screening Historical Sales Volume by End User (2021-2026)
7.3 Global Blood Screening Historical Revenue by End User (2021-2026)
7.4 Global Blood Screening Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Blood Screening Historical Sales Volume, Revenue and Growth Rate of Blood Banks (2021-2026)
7.5.2 Global Blood Screening Historical Sales Volume, Revenue and Growth Rate of Hospitals (2021-2026)

8 Leading Companies Profiles
8.1 BioMérieux (France)
8.1.1 BioMérieux (France) Corporation Information
8.1.2 BioMérieux (France) - Blood Screening Product Portfolio and Specification
8.1.3 BioMérieux (France) Performance Analysis (2021-2026)
8.1.4 BioMérieux (France) Business and Markets Served
8.1.5 BioMérieux (France) Recent Developments
8.2 Becton, Dickinson and Company (U.S)
8.2.1 Becton, Dickinson and Company (U.S) Corporation Information
8.2.2 Becton, Dickinson and Company (U.S) - Blood Screening Product Portfolio and Specification
8.2.3 Becton, Dickinson and Company (U.S) Performance Analysis (2021-2026)
8.2.4 Becton, Dickinson and Company (U.S) Business and Markets Served
8.2.5 Becton, Dickinson and Company (U.S) Recent Developments
8.3 Ortho Clinical Diagnostics, Inc. (U.S.)
8.3.1 Ortho Clinical Diagnostics, Inc. (U.S.) Corporation Information
8.3.2 Ortho Clinical Diagnostics, Inc. (U.S.) - Blood Screening Product Portfolio and Specification
8.3.3 Ortho Clinical Diagnostics, Inc. (U.S.) Performance Analysis (2021-2026)
8.3.4 Ortho Clinical Diagnostics, Inc. (U.S.) Business and Markets Served
8.3.5 Ortho Clinical Diagnostics, Inc. (U.S.) Recent Developments
8.4 Roche Diagnostics (Switzerland)
8.4.1 Roche Diagnostics (Switzerland) Corporation Information
8.4.2 Roche Diagnostics (Switzerland) - Blood Screening Product Portfolio and Specification
8.4.3 Roche Diagnostics (Switzerland) Performance Analysis (2021-2026)
8.4.4 Roche Diagnostics (Switzerland) Business and Markets Served
8.4.5 Roche Diagnostics (Switzerland) Recent Developments
8.5 Grifols (Spain)
8.5.1 Grifols (Spain) Corporation Information
8.5.2 Grifols (Spain) - Blood Screening Product Portfolio and Specification
8.5.3 Grifols (Spain) Performance Analysis (2021-2026)
8.5.4 Grifols (Spain) Business and Markets Served
8.5.5 Grifols (Spain) Recent Developments
8.6 Beckman Coulter, Inc. (U.S.)
8.6.1 Beckman Coulter, Inc. (U.S.) Corporation Information
8.6.2 Beckman Coulter, Inc. (U.S.) - Blood Screening Product Portfolio and Specification
8.6.3 Beckman Coulter, Inc. (U.S.) Performance Analysis (2021-2026)
8.6.4 Beckman Coulter, Inc. (U.S.) Business and Markets Served
8.6.5 Beckman Coulter, Inc. (U.S.) Recent Developments
8.7 Bio-Rad Laboratories, Inc. (U.S.)
8.7.1 Bio-Rad Laboratories, Inc. (U.S.) Corporation Information
8.7.2 Bio-Rad Laboratories, Inc. (U.S.) - Blood Screening Product Portfolio and Specification
8.7.3 Bio-Rad Laboratories, Inc. (U.S.) Performance Analysis (2021-2026)
8.7.4 Bio-Rad Laboratories, Inc. (U.S.) Business and Markets Served
8.7.5 Bio-Rad Laboratories, Inc. (U.S.) Recent Developments
8.8 Thermo Fisher Scientific, Inc. (U.S.)
8.8.1 Thermo Fisher Scientific, Inc. (U.S.) Corporation Information
8.8.2 Thermo Fisher Scientific, Inc. (U.S.) - Blood Screening Product Portfolio and Specification
8.8.3 Thermo Fisher Scientific, Inc. (U.S.) Performance Analysis (2021-2026)
8.8.4 Thermo Fisher Scientific, Inc. (U.S.) Business and Markets Served
8.8.5 Thermo Fisher Scientific, Inc. (U.S.) Recent Developments
8.9 Siemens Healthineers (Germany)
8.9.1 Siemens Healthineers (Germany) Corporation Information
8.9.2 Siemens Healthineers (Germany) - Blood Screening Product Portfolio and Specification
8.9.3 Siemens Healthineers (Germany) Performance Analysis (2021-2026)
8.9.4 Siemens Healthineers (Germany) Business and Markets Served
8.9.5 Siemens Healthineers (Germany) Recent Developments
8.10 Abbott Laboratories (U.S.)
8.10.1 Abbott Laboratories (U.S.) Corporation Information
8.10.2 Abbott Laboratories (U.S.) - Blood Screening Product Portfolio and Specification
8.10.3 Abbott Laboratories (U.S.) Performance Analysis (2021-2026)
8.10.4 Abbott Laboratories (U.S.) Business and Markets Served
8.10.5 Abbott Laboratories (U.S.) Recent Developments

9 Global Blood Screening Market Forecast by Product Type and End User (2026-2034)
9.1 Global Blood Screening Market Forecast by Product Type (2026-2034)
9.1.1 Global Blood Screening Sales Volume, Revenue Forecast and Growth Rate of First Generation (2026-2034)
9.1.2 Global Blood Screening Sales Volume, Revenue Forecast and Growth Rate of Second Generation (2026-2034)
9.1.3 Global Blood Screening Sales Volume, Revenue Forecast and Growth Rate of Third Generation (2026-2034)
9.1.4 Global Blood Screening Sales Volume, Revenue Forecast and Growth Rate of Fourth Generation & Above (2026-2034)
9.1.5 Global Blood Screening Sales Volume, Revenue Forecast and Growth Rate of Rapid Tests (2026-2034)
9.1.6 Global Blood Screening Sales Volume, Revenue Forecast and Growth Rate of Western Blot Assay (2026-2034)
9.1.7 Global Blood Screening Sales Volume, Revenue Forecast and Growth Rate of Next-generation Sequencing (NGS) (2026-2034)
9.2 Global Blood Screening Market Forecast by End User (2026-2034)
9.2.1 Global Blood Screening Sales Volume, Revenue Forecast and Growth Rate of Blood Banks (2026-2034)
9.2.2 Global Blood Screening Sales Volume, Revenue Forecast and Growth Rate of Hospitals (2026-2034)

10 Global Blood Screening Market Forecast by Geographic Region (2026-2034)
10.1 Global Blood Screening Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Blood Screening Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer